Biotech

All Articles

Galecto gets leukemia medication, loses bone tissue cancer resource in pivot

.A year after the failure of an idiopathic lung fibrosis applicant delivered Galecto on a look for s...

Judo throws down $100M to knock out renal disease

.Taking the mat is Judo Bio, an up-and-coming biotech equipped along with $one hundred thousand to c...

AstraZeneca pays out CSPC $100M for preclinical heart disease medicine

.AstraZeneca has paid CSPC Pharmaceutical Group $one hundred million for a preclinical heart disease...

Zephyrm finds Hong Kong IPO to cash phase 3 cell therapy tests

.Zephyrm Bioscience is gusting towards the Hong Kong stock market, filing (PDF) for an IPO to bankro...

Frazier Life Sciences gets $630M for tiny, mid-cap biotechs

.Frazier Life Sciences has sourced an even more $630 million for its fund paid attention to little a...

GigaGen amasses around $135M BARDA dollars to beat botox

.Antibody aficionado GigaGen, a subsidiary of Spanish biopharma Grifols, is actually increase its sp...

GPCR organization Septerna files for IPO on toughness of preclinical records

.Septerna will find out how a biotech without "any sort of significant professional data" meals in t...

Kurma closes initially $154M loot for most significant biotech fund yet

.International VC firm Kurma Partners has actually revealed its most recent biotech fund, with 140 t...

Prothena advertises one exec while yet another keeps-- Chutes &amp Ladders

.Invite to recently's Chutes &amp Ladders, our summary of considerable management hirings, firings a...

Editas profit Vertex Cas9 licensing rights for $57M

.Against the scenery of a Cas9 patent battle that rejects to pass away, Editas Medication is cashing...